Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Astrid Dalhaug

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Anticancer Research|April 16, 2010
A new prognostic score derived from phase I study participants with advanced solid tumours is also valid in patients with brain metastasisCarsten Nieder, Astrid Dalhaug
Anticancer Research|January 25, 2023
Prognostic Factors and Independent Validation of a Risk Stratification Model in Octogenarian Patients Irradiated for Brain MetastasesCarsten Nieder, Astrid Dalhaug
Anticancer Research|February 5, 2020
Confirmatory Analysis of QUARTZ Study Results: Survival Prolongation After Whole-brain RadiotherapyCarsten Nieder, Astrid Dalhaug, Adam Pawinski
Case Reports in Oncological Medicine|September 7, 2012
A case of brain metastases from breast cancer treated with whole-brain radiotherapy and eribulin mesylateCarsten Nieder, Gro Aandahl, Astrid Dalhaug
In Vivo (Athens, Greece)|March 4, 2022
Established Serum Biomarkers Are Prognostic Factors in Patients With Oligometastatic Cancer and Brain InvolvementCarsten Nieder, Astrid Dalhaug, Bård Mannsåker
Journal of Clinical Medicine Research|February 26, 2020
Independent External Validation of a Score Predicting Survival After Radiotherapy for Bone Metastases and Expansion to Patients Treated With Single Fraction RadiotherapyCarsten Nieder, Bard Mannsaker, Astrid Dalhaug
In Vivo (Athens, Greece)|December 28, 2018
Serum Lactate Dehydrogenase Contributes to Prognostic Assessment in Patients With Oligometastatic Cancer and Brain InvolvementCarsten Nieder, Astrid Dalhaug, Adam Pawinski
World Journal of Surgical Oncology|May 6, 2010
Leptomeningeal carcinomatosis from renal cell cancer: treatment attempt with radiation and sunitinib (case report)Astrid Dalhaug, Ellinor Haukland, Carsten Nieder
British Journal of Neurosurgery|June 13, 2012
Contribution of case reports to glioblastoma research: systematic review and analysis of pattern of citationCarsten Nieder, Adam Pawinski, Astrid Dalhaug
Radiation Oncology (London, England)|April 12, 2013
Continuous controversy about radiation oncologists' choice of treatment regimens for bone metastases: should we blame doctors, cancer-related features, or design of previous clinical studies?Carsten Nieder, Adam Pawinski, Astrid Dalhaug
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Anticancer Research|April 16, 2010
A new prognostic score derived from phase I study participants with advanced solid tumours is also valid in patients with brain metastasisCarsten Nieder, Astrid Dalhaug
Anticancer Research|January 25, 2023
Prognostic Factors and Independent Validation of a Risk Stratification Model in Octogenarian Patients Irradiated for Brain MetastasesCarsten Nieder, Astrid Dalhaug
Anticancer Research|February 5, 2020
Confirmatory Analysis of QUARTZ Study Results: Survival Prolongation After Whole-brain RadiotherapyCarsten Nieder, Astrid Dalhaug, Adam Pawinski
Case Reports in Oncological Medicine|September 7, 2012
A case of brain metastases from breast cancer treated with whole-brain radiotherapy and eribulin mesylateCarsten Nieder, Gro Aandahl, Astrid Dalhaug
In Vivo (Athens, Greece)|March 4, 2022
Established Serum Biomarkers Are Prognostic Factors in Patients With Oligometastatic Cancer and Brain InvolvementCarsten Nieder, Astrid Dalhaug, Bård Mannsåker
Journal of Clinical Medicine Research|February 26, 2020
Independent External Validation of a Score Predicting Survival After Radiotherapy for Bone Metastases and Expansion to Patients Treated With Single Fraction RadiotherapyCarsten Nieder, Bard Mannsaker, Astrid Dalhaug
In Vivo (Athens, Greece)|December 28, 2018
Serum Lactate Dehydrogenase Contributes to Prognostic Assessment in Patients With Oligometastatic Cancer and Brain InvolvementCarsten Nieder, Astrid Dalhaug, Adam Pawinski
World Journal of Surgical Oncology|May 6, 2010
Leptomeningeal carcinomatosis from renal cell cancer: treatment attempt with radiation and sunitinib (case report)Astrid Dalhaug, Ellinor Haukland, Carsten Nieder
British Journal of Neurosurgery|June 13, 2012
Contribution of case reports to glioblastoma research: systematic review and analysis of pattern of citationCarsten Nieder, Adam Pawinski, Astrid Dalhaug
Radiation Oncology (London, England)|April 12, 2013
Continuous controversy about radiation oncologists' choice of treatment regimens for bone metastases: should we blame doctors, cancer-related features, or design of previous clinical studies?Carsten Nieder, Adam Pawinski, Astrid Dalhaug
Pageof 8